Lombard Odier Asset Management (Europe)’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-175,000
| Closed | -$1.97M | – | 165 |
|
|
2024
Q4 | $1.97M | Hold |
175,000
| – | – | 0.13% | 159 |
|
|
2024
Q3 | $4.95M | Sell |
175,000
-25,000
| -13% | -$707K | 0.21% | 139 |
|
|
2024
Q2 | $3.82M | Buy |
200,000
+187,000
| +1,438% | +$3.58M | 0.18% | 149 |
|
|
2024
Q1 | $426K | Hold |
13,000
| – | – | 0.03% | 205 |
|
|
2023
Q4 | $429K | Sell |
13,000
-3,000
| -19% | -$99.1K | 0.02% | 208 |
|
|
2023
Q3 | $436K | Hold |
16,000
| – | – | 0.02% | 225 |
|
|
2023
Q2 | $485K | Sell |
16,000
-2,000
| -11% | -$60.6K | 0.02% | 228 |
|
|
2023
Q1 | $584K | Sell |
18,000
-2,500
| -12% | -$81.1K | 0.03% | 244 |
|
|
2022
Q4 | $576K | Sell |
20,500
-4,500
| -18% | -$126K | 0.02% | 248 |
|
|
2022
Q3 | $898K | Sell |
25,000
-8,000
| -24% | -$287K | 0.05% | 225 |
|
|
2022
Q2 | $1.01M | Buy |
+33,000
| New | +$1.01M | 0.05% | 212 |
|